Author:
Casas Francesc,Oses Gabriela,Muñoz-Guglielmetti Diego,Mases Joel,Antelo Gabriela,Jeremic Branislav
Reference28 articles.
1. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): A phase 3, open-label, randomised controlled trial;Ball;The Lancet Oncology,2019
2. Prospective, risk adapted strategy of stereotactic body radiotherapy for early – stage non-small-cell lung cancer: Results of a phase II trial;Bral;International Journal of Radiation Oncology, Biology, Physics,2011
3. The tumor radiobiology of SRS and SBRT: Are more than the 5 Rs involved?;Brown;International Journal of Radiation Oncology, Biology, Physics,2014
4. Rational use of intensity –modulated radiation therapy: The importance of clinical outcome;De Neve;Seminars in Radiation Oncology,2012
5. European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer;De Ruysscher;Radiotherapy and Oncology,2017